These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8085857)

  • 1. [A case of inflammatory breast cancer successfully treated with 5'-DFUR and MPA].
    Kusama M; Koyanagi Y; Sekine M; Serizawa H; Ebihara Y; Hirota T; Nakamura Y; Matsunaga T
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2049-52. PubMed ID: 8085857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
    Kobayashi J; Kubota K; Ishikawa H; Asaumi S; Iwanami K; Matsumoto H; Kawashima K; Yokoe T; Iino Y; Morishita Y
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2513-6. PubMed ID: 7944501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of breast cancer with multiple organ metastases in which single low dose administration of 5'-DFUR proved effective].
    Kataoka T; Okamoto T; Gotoh T; Sadamoto S; Nishiki M; Dohi K
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):299-302. PubMed ID: 8434970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced breast cancer receiving combination therapy with 5'-DFUR and MPA with remarkable results].
    Nishibe M; Kuribayashi H; Sato T; Watanabe I; Nishihara H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1149-52. PubMed ID: 9239169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
    Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
    Toi M; Taniguchi T; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
    Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA].
    Kihara M; Matsusaka K; Miyauchi A; Maeda M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2123-6. PubMed ID: 9838917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases].
    Otani S; Toyota N; Nozaka K; Wakatsuki T; Takebayashi M; Kamasako A; Tanida O; Hashiguchi H; Ohgami Y; Hirooka Y
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2151-3. PubMed ID: 15628761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
    Fujitake S; Maeda Y; Shimizu M; Nozaki H; Tohyama M; Kataoka S
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1177-80. PubMed ID: 10431585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of complete response of breast cancer with pulmonary metastases to combination therapy of 5'-DFUR and MPA].
    Senga O; Miyakawa M; Hikita H; Horigome N; Kouzu S; Kuwae K; Hanaoka T; Yoshida K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2655-8. PubMed ID: 7979428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
    Yoshinaka K; Yagi M; Ohtagaki S; Toi M; Toge T
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):115-8. PubMed ID: 1824814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
    Kim R; Osaki A; Tanabe K; Kojima J; Toge T
    Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
    Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced breast cancer that responded remarkably to chemotherapy].
    Watanabe Y; Kaiga T; Ueda T; Fujii M
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2113-6. PubMed ID: 11103244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A long-surviving patient with Stage IV breast cancer with no recurrence after combined therapy of medroxy progesterone acetate (MPA) and intra-arterial infusion chemotherapy].
    Yamada T; Yuyama Y; Okazaki Y
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1387-9. PubMed ID: 15446562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of advanced recurent breast cancer using DMpC therapy as maintenance therapy].
    Miyamoto H; Yoshida S; Imatomi M; Saitoh T; Nakata A
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):427-9. PubMed ID: 11915733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
    Kihara M; Kontani K; Yamauchi A; Yokomise H
    Gan To Kagaku Ryoho; 2005 May; 32(5):683-6. PubMed ID: 15918573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive response to oral chemoendocrine combination therapy using 5"-deoxy-5-fluorouridine for locally advanced breast cancer with carcinomatous pleurisy: report of a case.
    Suzuki O; Sekishita Y; Shiono T; Kondo S; Kato H
    Surg Today; 2003; 33(12):913-6. PubMed ID: 14669082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.